Background: Genomic information could help to reduce the morbidity effects of inappropriate treatment decisions in many disease areas, in particular cancer. However, evidence of the benefits that patients derive from genomic testing is limited. This study evaluated patient preferences for genomic testing in the context of chronic lymphocytic leukaemia (CLL).Expand abstract
Methods: We used a discrete choice experiment (DCE) survey to assess the preferences of CLL patients in the United Kingdom fo...
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Copyright holder:
- Springer International Publishing
- Copyright date:
- © The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License.
Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record